Authors: Manz, M Riessen, R Poll, L Dohmen, B Kaiserling, E Kruck, W Laniado, M Kanz, L Denzlinger, C

Citation: M. Manz et al., High-grade lymphoma mimicking bone crisis in Gaucher's disease, BR J HAEM, 113(1), 2001, pp. 191-193

Authors: Bautz, F Denzlinger, C Kanz, L Mohle, R

Citation: F. Bautz et al., Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1, BLOOD, 97(11), 2001, pp. 3433-3440

Authors: Denzlinger, C Bowen, D Benz, D Gelly, K Brugger, W Kanz, L

Citation: C. Denzlinger et al., Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia, BR J HAEM, 108(1), 2000, pp. 93-95

Authors: Schleuning, M Jager, G Holler, E Hill, W Thomssen, C Denzlinger, C Lorenz, T Ledderose, G Wilmanns, W Kolb, HJ

Citation: M. Schleuning et al., Human parvovirus B19-associated disease in bone marrow transplantation, INFECTION, 27(2), 1999, pp. 114-117

Authors: Brugger, D Herbart, H Gekeler, V Seitz, G Liu, C Klingebiel, T Orlikowsky, T Einsele, H Denzlinger, C Bader, P Niethammer, D Beck, JF

Citation: D. Brugger et al., Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts, LEUK RES, 23(5), 1999, pp. 467-475

Authors: Bowen, DT Denzlinger, C Brugger, W Culligan, D Gelly, K Adlakha, S Groves, M Hepburn, M Kanz, L

Citation: Dt. Bowen et al., Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients, BR J HAEM, 103(3), 1998, pp. 785-787